Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Immunol Methods. 2017 Apr 6;446:47–53. doi: 10.1016/j.jim.2017.03.021

Figure 4.

Figure 4

Representative images of the (A) ovary and (B) kidney 38 days post-engraftment displaying level of Daudi cell engraftment (brown stained cells) in different cohorts of age- and sex-matched rituximab-treated NSG and NSG-Hc1 mice. Low-magnification images at top right showing anti-CD45 staining IHC, at bottom right showing H&E staining, (×10, scale bar = 200um) showing; high-magnification image (×20, scale bar = 100um) showing anti-human CD45 IHC. PBS, phosphate buffer saline; RTX, rituximab. There were also increased numbers of Daudi cells in the livers, spleens, lungs, and lymph nodes of NSG mice (data not shown).